{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:18:36Z","timestamp":1790007516087,"version":"4.0.1"},"reference-count":24,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["2022R1A2C2009221"],"award-info":[{"award-number":["2022R1A2C2009221"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean government"},{"name":"Dong-A ST Co"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>G protein\u2013coupled receptor 119 (GPR119) is predominantly expressed in pancreatic \u03b2-cells, enteroendocrine cells, and the liver. It is a novel therapeutic for dyslipidemia and type 2 diabetes. DA-1241, a GPR119 agonist, improves glucose tolerance by inhibiting gluconeogenesis and enhancing insulin secretion. It mitigates hepatic inflammation by inhibiting NF\u03baB signaling. However, the mechanism by which DA-1241 ameliorates nonalcoholic fatty liver disease (NAFLD) remains unknown. We hypothesized that DA-1241 improves liver steatosis by inducing autophagy in a transcriptional factor EB (TFEB)-dependent manner. It induced autophagy and TFEB nuclear translocation, and decreased lipid content in liver cell lines. Lysotracker staining and DQ-Red BSA assay revealed it increased lysosomal activity. Furthermore, DA-1241 increased the colocalization of mRFP-LC3 and lipid droplets, which were completely abolished by GPR119 knockdown. DA-1241 treatment improved glucose tolerance and insulin sensitivity, reduced liver enzymes activity and hepatic triglyceride levels, and decreased the NAFLD activity score, accompanied by an increased number of autophagosomes and lysosomes in high-fat diet\u2013fed mice. Despite DA-1241 treatment, lysosomal activity and subsequent lipid content reduction were not induced in tfeb knockout HeLa cells. DA-1241 treatment failed to produce favorable metabolic effects, including reduced hepatic triglyceride levels, in liver-specific Tfeb knockout mice. Thus, DA-1241 attenuates hepatic steatosis through TFEB-mediated autophagy induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>DA-1241 is a novel small-molecule GPR119 agonist. DA-1241 treatment stimulates autophagy induction and transcriptional factor EB (TFEB) nuclear translocation and subsequently reduces hepatic fat accumulation both in\u00a0vitro and in\u00a0vivo. DA-1241 treatment increases the lysosomal activity and colocalization of mRFP-LC3 with lipid droplets. The antisteatotic effect of DA-1241 is offset by GPR119 knockdown or in tfeb knockout HeLa cells and liver-specific Tfeb knockout mice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db24-0370","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T12:31:06Z","timestamp":1743165066000},"page":"1107-1120","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":5,"title":["DA-1241, a GPR119 Agonist, Ameliorates Fatty Liver Through the Upregulation of TFEB-Mediated Autophagy"],"prefix":"10.2337","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-350X","authenticated-orcid":false,"given":"Jin","family":"Yoo","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, Graduate School, Kyung Hee University 1 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Jun","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine 2 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Kyung","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine 2 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Jeung","family":"Ahn","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine 2 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yeon","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine 2 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Shik","family":"Lee","sequence":"additional","affiliation":[{"name":"Soonchunhyang Institute of Medi-bio Science and Division of Endocrinology, Department of Internal Medicine, Soonchunhyang University College of Medicine 3 , Cheonan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-7874","authenticated-orcid":false,"given":"You-Cheol","family":"Hwang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine 2 , Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"2026061113024666300_B1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.aohep.2020.06.001","article-title":"Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease","volume":"19","author":"Ding","year":"2020","journal-title":"Ann Hepatol"},{"key":"2026061113024666300_B2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"2026061113024666300_B3","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10620-015-4025-x","article-title":"Function of autophagy in nonalcoholic fatty liver disease","volume":"61","author":"Czaja","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2026061113024666300_B4","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.3390\/ijms231710055","article-title":"Autophagy dysregulation in metabolic associated fatty liver disease: a new therapeutic target","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026061113024666300_B5","first-page":"72","article-title":"The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res"},{"key":"2026061113024666300_B6","doi-asserted-by":"crossref","first-page":"105964","DOI":"10.1016\/j.phrs.2021.105964","article-title":"Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease","volume":"174","author":"Zhang","year":"2021","journal-title":"Pharmacol Res"},{"key":"2026061113024666300_B7","doi-asserted-by":"crossref","first-page":"154798","DOI":"10.1016\/j.metabol.2021.154798","article-title":"Fenofibrate, a PPAR\u03b1 agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy","volume":"120","author":"Yoo","year":"2021","journal-title":"Metabolism"},{"key":"2026061113024666300_B8","doi-asserted-by":"crossref","first-page":"120179","DOI":"10.1155\/2014\/120179","article-title":"Autophagy and non-alcoholic fatty liver disease","volume":"2014","author":"Lavallard","year":"2014","journal-title":"Biomed Res Int"},{"key":"2026061113024666300_B9","doi-asserted-by":"crossref","first-page":"eabf8271","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"key":"2026061113024666300_B10","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.1038\/s41598-021-99958-7","article-title":"Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways","volume":"11","author":"Paquette","year":"2021","journal-title":"Sci Rep"},{"key":"2026061113024666300_B11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11658-021-00276-7","article-title":"Targeting the GPR119\/incretin axis: a promising new therapy for metabolic-associated fatty liver disease","volume":"26","author":"Zhao","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"2026061113024666300_B12","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbrc.2017.12.004","article-title":"Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet","volume":"495","author":"Bahirat","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2026061113024666300_B13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1096\/fj.15-273771","article-title":"GPR119: a promising target for nonalcoholic fatty liver disease","volume":"30","author":"Yang","year":"2016","journal-title":"Faseb J"},{"key":"2026061113024666300_B14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4093\/dmj.2021.0056","article-title":"DA-1241, a novel GPR119 agonist, improves hyperglycaemia by inhibiting hepatic gluconeogenesis and enhancing insulin secretion in diabetic mice","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"2026061113024666300_B15","doi-asserted-by":"crossref","first-page":"112324","DOI":"10.1016\/j.biopha.2021.112324","article-title":"A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression","volume":"144","author":"Kim","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2026061113024666300_B16","doi-asserted-by":"crossref","first-page":"115345","DOI":"10.1016\/j.biopha.2023.115345","article-title":"GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NF\u03baB signaling","volume":"166","author":"Lee","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026061113024666300_B17","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.3748\/wjg.v20.i23.7325","article-title":"Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue","volume":"20","author":"Kwanten","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026061113024666300_B18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/ijms24021324","article-title":"Increased hepatic ATG7 mRNA and ATG7 protein expression in nonalcoholic steatohepatitis associated with obesity","volume":"24","author":"Barrientos-Riosalido","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026061113024666300_B19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13046-018-0949-2","article-title":"GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy","volume":"37","author":"Im","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"2026061113024666300_B20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajpath.2021.10.004","article-title":"Loss of hepatic transcription factor EB attenuates alcohol-associated liver carcinogenesis","volume":"192","author":"Chao","year":"2022","journal-title":"Am J Pathol"},{"key":"2026061113024666300_B21","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","article-title":"AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3","volume":"17","author":"Paquette","year":"2021","journal-title":"Autophagy"},{"key":"2026061113024666300_B22","doi-asserted-by":"crossref","first-page":"E763","DOI":"10.1152\/ajpendo.00339.2020","article-title":"Transcription factor EB and TFE3: new metabolic coordinators mediating adaptive responses to exercise in skeletal muscle?","volume":"319","author":"Markby","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026061113024666300_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2017.06.030","article-title":"TFEB-mediated activation of the lysosome-autophagy system affects the transduction efficiency of adeno-associated virus 2","volume":"510","author":"Popp","year":"2017","journal-title":"Virology"},{"key":"2026061113024666300_B24","doi-asserted-by":"crossref","first-page":"40797","DOI":"10.1038\/srep40797","article-title":"TFEB-mediated increase in peripheral lysosomes regulates store-operated calcium entry","volume":"7","author":"Sbano","year":"2017","journal-title":"Sci Rep"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/7\/1107\/802712\/db240370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/7\/1107\/802712\/db240370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:02:56Z","timestamp":1781197376000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/74\/7\/1107\/158049\/DA-1241-a-GPR119-Agonist-Ameliorates-Fatty-Liver"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db24-0370","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}